Physician profile
Denise Mastromonaco
NPI 1336399112
$1,328.30
in general payments reported to CMS, 2019-2025
17 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2021: $114 · 2023: $270 · 2024: $248 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.50 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $212.35 | 2019-2025 | Dupixent |
| Janssen Biotech, INC. | $211.53 | 2019-2024 | Tremfya |
| Ucb, INC. | $194.60 | 2019-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $139.11 | 2023-2024 | Sotyktu |
| Incyte Corporation | $114.23 | 2021 | |
| Novartis Pharmaceuticals Corporation | $93.09 | 2019-2024 | |
| Abbvie INC. | $90.31 | 2019-2024 | |
| Lilly USA, LLC | $53.02 | 2023-2024 | Olumiant, Taltz |
| Almirall LLC | $45.18 | 2019 | |
| Genzyme Corporation | $44.28 | 2019 | |
| Arcutis Biotherapeutics, INC. | $30.41 | 2023-2024 | Zoryve |
| Sun Pharmaceutical Industries INC. | $21.99 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $19.92 | 2019 | |
| Amgen INC. | $15.88 | 2023 | Otezla |
| Helsinn Therapeutics (U.S.), INC. | $15.54 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dermavant Sciences, INC. | $13.52 | 2024 | Vtama |
| Pfizer INC. | $13.34 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denise Mastromonaco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.